Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125268401 | 12526840 | 1 | I | 20160321 | 20160620 | 20160705 | 20160705 | EXP | PL-CELGENEUS-POL-2016065249 | CELGENE | 64.20 | YR | M | Y | 62.50000 | KG | 20160705 | MD | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125268401 | 12526840 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | 25 MILLIGRAM | U | 21880 | 25 | MG | CAPSULES | QD | |||||
| 125268401 | 12526840 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | U | 0 | 40 | MG | UNKNOWN | QD | ||||||
| 125268401 | 12526840 | 3 | C | CLODRONATE | CLODRONATE DISODIUM | 1 | Unknown | 40 MILLIGRAM | 0 | UNKNOWN | |||||||||
| 125268401 | 12526840 | 4 | C | THIAMAZOLE | METHIMAZOLE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125268401 | 12526840 | 5 | C | ACICLOVIR | ACYCLOVIR | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125268401 | 12526840 | 6 | C | ENOXAPARIN | ENOXAPARIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125268401 | 12526840 | 7 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125268401 | 12526840 | 1 | Plasma cell myeloma |
| 125268401 | 12526840 | 2 | Plasma cell myeloma |
| 125268401 | 12526840 | 3 | Product used for unknown indication |
| 125268401 | 12526840 | 4 | Product used for unknown indication |
| 125268401 | 12526840 | 5 | Product used for unknown indication |
| 125268401 | 12526840 | 6 | Product used for unknown indication |
| 125268401 | 12526840 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125268401 | 12526840 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125268401 | 12526840 | Plasma cell myeloma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125268401 | 12526840 | 1 | 20120724 | 20140707 | 0 | |
| 125268401 | 12526840 | 2 | 20120724 | 20140708 | 0 | |
| 125268401 | 12526840 | 3 | 20120626 | 0 | ||
| 125268401 | 12526840 | 4 | 20120626 | 0 | ||
| 125268401 | 12526840 | 5 | 20121002 | 0 | ||
| 125268401 | 12526840 | 6 | 20121017 | 0 | ||
| 125268401 | 12526840 | 7 | 20131112 | 0 |